Vasundhara Rasayans Ltd Stock Price Today (NSE: VRL)
Fundamental Score
Vasundhara Rasayans Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Vasundhara Rasayans Ltd share price today is ₹105.65, up +0.00% on NSE/BSE as of 30 March 2026. Vasundhara Rasayans Ltd (VRL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹63.04 (Cr). The 52-week high for VRL share price is ₹267.00 and the 52-week low is ₹101.15. At a P/E ratio of 13.92x, VRL is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 12.59% and a debt-to-equity ratio of 0.14.
Vasundhara Rasayans Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Vasundhara Rasayans Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Vasundhara Rasayans Share Price: A ROCE-Focused Financial Analysis
The pharmaceutical industry, often insulated by patent protection and brand loyalty, faces increasing pressures to optimize capital allocation. This analysis examines the financial health of Vasundhara Rasayans Ltd, focusing on Return on Capital Employed (ROCE). The current Vasundhara Rasayans share price stands at ₹151.300003, with a Price-to-Earnings (PE) ratio of 13.92 and a ROCE of 16.56%. This analysis forms part of a more extensive 80-parameter fundamental audit, meticulously verified by Sweta Mishra.
Vasundhara Rasayans' ROCE of 16.56% indicates the efficiency with which the company generates profits from its invested capital. A higher ROCE generally suggests a stronger ability to create value for shareholders. A consistent and robust ROCE, like this, can contribute significantly to the company's economic moat. This moat, or competitive advantage, is strengthened by the company's ability to reinvest profits effectively, further solidifying its market position and potentially leading to sustainable growth.
Comparing Vasundhara Rasayans to its peers, such as Mankind Pharma Ltd, Smruthi Organics Ltd, and Balaxi Pharmaceuticals Ltd, offers valuable context. While a detailed comparison of financial metrics is beyond the scope of this focused analysis, it's crucial to consider factors like management quality and operational efficiency across the sector. For example, while
Mankind Pharma Ltd may command a premium valuation due to perceived higher management quality and brand recognition, a deep dive into Vasundhara Rasayans' management effectiveness and capital allocation strategies is essential to understand its long-term potential.The current PE ratio of 13.92 suggests that the market is pricing Vasundhara Rasayans at a moderate level relative to its earnings. Whether this represents an undervaluation or fair valuation hinges on factors like future growth prospects, the sustainability of its ROCE, and the overall risk profile of the company. Further analysis, encompassing cash flow generation, debt levels, and industry trends, is needed to form a comprehensive investment thesis. This analysis is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Vasundhara Rasayans Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VRL across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Excellent ROCE Performance (16.56%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 13.92 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (40.14%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.14)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (17.68x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (61.98%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Revenue Contraction (-9.82%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-1.28 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Vasundhara Rasayans Ltd Financial Statements
Comprehensive financial data for Vasundhara Rasayans Ltd including income statement, balance sheet and cash flow
About VRL (Vasundhara Rasayans Ltd)
Vasundhara Rasayans Ltd is a distinguished pharmaceutical manufacturer, specializing in the development, production, and global distribution of high-quality Active Pharmaceutical I...ngredients (APIs), particularly within the critical antacid therapeutic category. With a steadfast commitment to excellence and innovation, VRL caters to the ever-evolving needs of the pharmaceutical industry, supplying a comprehensive portfolio of antacid APIs renowned for their purity, efficacy, and adherence to stringent regulatory standards. Beyond simple manufacturing, VRL positions itself as a strategic partner to its clients, providing extensive technical support and collaborative solutions that ensure the seamless integration of its APIs into diverse pharmaceutical formulations. At the heart of VRL's product offerings lies a diverse array of antacid APIs, meticulously crafted to meet the varying demands of pharmaceutical manufacturers worldwide. This includes aluminum hydroxide gel, magnesium hydroxide, magaldrate, magnesium trisilicate, and aluminum phosphate, each meticulously manufactured to ensure optimal performance and safety. Moreover, VRL's commitment to pushing boundaries is showcased through its specialized offerings like aluminum hydroxide gel with low heavy lead content for sensitive applications, as well as advanced products tailored for lake color applications and aluminum hydroxide amorphous. The company distinguishes itself through a holistic approach, integrating manufacturing expertise with a focus on sustainability and responsible production practices. VRL aims to deliver exceptional value to its customers by providing not just APIs, but also a full range of support services, including formulation assistance, regulatory guidance, and customized solutions. By continually investing in research, technology, and its people, Vasundhara Rasayans Ltd is poised to further strengthen its position as a trusted and reliable partner in the global pharmaceutical landscape.
Company Details
Key Leadership
Corporate Events
Latest News
VRL Share Price: Frequently Asked Questions
What is the current share price of Vasundhara Rasayans Ltd (VRL)?
As of 30 Mar 2026, 12:07 pm IST, Vasundhara Rasayans Ltd share price is ₹105.65. The VRL stock has a market capitalisation of ₹63.04 (Cr) on NSE/BSE.
Is VRL share price Overvalued or Undervalued?
VRL share price is currently trading at a P/E ratio of 13.92x, compared to the industry average of 31.77x. Based on this relative valuation, the Vasundhara Rasayans Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of VRL share price?
The 52-week high of VRL share price is ₹267.00 and the 52-week low is ₹101.15. These values are updated daily from NSE/BSE price data.
What factors affect the Vasundhara Rasayans Ltd share price?
Key factors influencing VRL share price include quarterly earnings growth (Sales Growth: -9.82%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Vasundhara Rasayans Ltd a good stock for long-term investment?
Vasundhara Rasayans Ltd shows a 5-year Profit Growth of 7.72% and an ROE of 12.59%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.14 before investing in VRL shares.
How does Vasundhara Rasayans Ltd compare with its industry peers?
Vasundhara Rasayans Ltd competes with major peers in the Pharmaceuticals. Investors should compare VRL share price P/E of 13.92x and ROE of 12.59% against the industry averages to determine competitive standing.
What is the P/E ratio of VRL and what does it mean?
VRL share price has a P/E ratio of 13.92x compared to the industry average of 31.77x. Investors pay ₹14 for every ₹1 of annual earnings.
How is VRL performing according to Bull Run's analysis?
VRL has a Bull Run fundamental score of 49.4/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does VRL belong to?
VRL operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Vasundhara Rasayans Ltd share price.
What is Return on Equity (ROE) and why is it important for VRL?
VRL has an ROE of 12.59%, which shows decent profitability but room for improvement. ROE measures how efficiently Vasundhara Rasayans Ltd generates profits from shareholders capital.
How is VRL debt-to-equity ratio and what does it indicate?
VRL has a debt-to-equity ratio of 0.14, which indicates conservative financing with low financial risk.
What is VRL dividend yield and is it a good dividend stock?
VRL offers a dividend yield of 1.01%, meaning you receive ₹1.01 annual dividend for every ₹100 invested in Vasundhara Rasayans Ltd shares.
How has VRL share price grown over the past 5 years?
VRL has achieved 5-year growth rates of: Sales Growth 9.93%, Profit Growth 7.72%, and EPS Growth 7.72%.
What is the promoter holding in VRL and why does it matter?
Promoters hold 61.98% of VRL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Vasundhara Rasayans Ltd.
What is VRL market capitalisation category?
VRL has a market capitalisation of ₹63 crores, placing it in the Small-cap category.
How volatile is VRL stock?
VRL has a beta of N/A. A beta > 1 suggests the Vasundhara Rasayans Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is VRL operating profit margin trend?
VRL has a 5-year average Operating Profit Margin (OPM) of 13.54%, indicating the company's operational efficiency.
How is VRL quarterly performance?
Recent quarterly performance shows Vasundhara Rasayans Ltd YoY Sales Growth of -9.82% and YoY Profit Growth of 40.14%.
What is the institutional holding pattern in VRL?
VRL has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Vasundhara Rasayans Ltd stock.